Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives

{"This":[0,177],"study":[1,178],"examined":[2],"the":[3,20,54,223],"perceived":[4,80],"impacts":[5,81,95,139,151],"of":[6,22,38,98,140,206],"New":[7],"South":[8],"Wales'":[9],"(NSW)":[10],"statewide":[11],"prescription":[12,91],"drug":[13],"monitoring":[14],"program":[15],"(PDMP;":[16],"\\"SafeScript":[17],"NSW\\")":[18],"from":[19,130],"perspective":[21],"prescribers":[23,32,106],"and":[24,33,46,89,100,107,164,170,195,209,218,222],"pharmacists,":[25],"using":[26],"a":[27],"qualitative":[28],"descriptive":[29],"design.":[30],"Fourteen":[31],"pharmacists":[34,108],"who":[35,132],"were":[36,59,125,146,172],"users":[37,212],"NSW's":[39],"PDMP":[40,141,160],"completed":[41],"semi-structured":[42],"interviews":[43],"between":[44,122],"May":[45],"August":[47],"2024.":[48],"Thematic":[49],"analysis":[50],"was":[51],"guided":[52],"by":[53,175],"Quadruple":[55],"Aim":[56],"framework.":[57],"Impacts":[58,119],"classified":[60],"as":[61],"those":[62,131],"relating":[63,152],"to":[64,153,197],"(1)":[65],"population":[66,83],"health":[67,84],"outcomes,":[68],"(2)":[69],"patients'":[70],"care":[71],"experience,":[72],"(3)":[73],"costs,":[74],"(4)":[75],"practitioners'":[76,154,183],"work":[77],"experience.":[78],"PDMP's":[79],"on":[82,120,142,181,185],"included":[85,96],"improved":[86,110],"medication":[87],"safety":[88],"reduced":[90],"shopping.":[92],"Key":[93],"patient":[94],"risk":[97],"stigma":[99],"treatment":[101],"interruption.":[102],"Despite":[103],"these,":[104],"both":[105],"reported":[109,159],"therapeutic":[111],"relationships":[112,121],"with":[113,127,211],"patients":[114],"following":[115],"SafeScript":[116,136],"NSW":[117],"use.":[118],"healthcare":[123,143,182],"practitioners":[124],"mixed,":[126],"resistance":[128],"encountered":[129],"do":[133],"not":[134],"use":[135,161],"NSW.":[137],"No":[138],"delivery":[144],"costs":[145],"reported.":[147],"Participants":[148],"discussed":[149],"efficiency":[150],"work.":[155],"Both":[156],"practitioner":[157],"groups":[158],"increased":[162],"confidence":[163],"safer":[165],"prescribing/dispensing":[166],"practices.":[167],"Workflow":[168],"misalignment":[169],"workarounds":[171],"reported,":[173],"predominantly":[174],"pharmacists.":[176],"adds":[179],"evidence":[180],"perspectives":[184],"PDMP.":[186],"To":[187],"minimize":[188],"negative":[189],"impacts,":[190],"we":[191],"suggest":[192],"further":[193],"evaluation":[194],"strategies":[196,210],"address":[198],"user-identified":[199],"gaps,":[200],"including":[201],"workflow":[202],"challenges.":[203],"Collaborative":[204],"development":[205],"system":[207],"improvements":[208],"can":[213],"maximize":[214],"continued":[215],"user":[216],"acceptance":[217],"uptake,":[219],"benefits":[220],"realization,":[221],"system's":[224],"long-term":[225],"success.":[226]}

Authors

Institutions

Publication Details

Journal
Pharmacology Research & Perspectives
Published
2026-09-18
DOI
https://doi.org/10.1002/prp2.70326
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives

Tracey‐Lea Laba, Meredith Makeham, Emma Tay, Melissa Baysari
Pharmacology Research & Perspectives
Pharmaceutical Practices and Patient Outcomes
article

Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives

Tracey‐Lea Laba, Meredith Makeham, Emma Tay, Melissa Baysari
article en

Abstract

This study examined the perceived impacts of New South Wales' (NSW) statewide prescription drug monitoring program (PDMP; "SafeScript NSW") from the perspective of prescribers and pharmacists, using a qualitative descriptive design. Fourteen prescribers and pharmacists who were users of NSW's PDMP completed semi-structured interviews between May and August 2024. Thematic analysis was guided by the Quadruple Aim framework. Impacts were classified as those relating to (1) population health outcomes, (2) patients' care experience, (3) costs, (4) practitioners' work experience. PDMP's perceived impacts on population health included improved medication safety and reduced prescription shopping. Key patient impacts included risk of stigma and treatment interruption. Despite these, both prescribers and pharmacists reported improved therapeutic relationships with patients following SafeScript NSW use. Impacts on relationships between healthcare practitioners were mixed, with resistance encountered from those who do not use SafeScript NSW. No impacts of PDMP on healthcare delivery costs were reported. Participants discussed efficiency impacts relating to practitioners' work. Both practitioner groups reported PDMP use increased confidence and safer prescribing/dispensing practices. Workflow misalignment and workarounds were reported, predominantly by pharmacists. This study adds evidence on healthcare practitioners' perspectives on PDMP. To minimize negative impacts, we suggest further evaluation and strategies to address user-identified gaps, including workflow challenges. Collaborative development of system improvements and strategies with users can maximize continued user acceptance and uptake, benefits realization, and the system's long-term success.

Pharmacology Research & PerspectivesVol. 14(5)
University of Technology Sydney (AU), The University of Sydney (AU), Sydney Local Health District (AU), South Western Sydney Local Health District (AU), Macquarie University (AU)
Avant Foundation
Openalex Percentile: Top 14%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.